Diabetic Foot Files

This episode explains Erysipelothrix rhusiopathiae, an animal-associated bacterium that can enter through minor skin breaks—often from fish, meat, or livestock exposure—and cause a localized lesion called erysipeloid.

It highlights diagnostic traps in diabetic foot care, the importance of occupational history (remember FISH: Fish exposure, Inoculation, Slowly expanding lesion, Heart involvement), the organism's intrinsic resistance to vancomycin, and the potential for systemic disease including endocarditis.

Dr. G explains why informed consent in diabetic foot care is more than paperwork: it’s a time-sensitive conversation about capacity, risks, alternatives, and what happens if treatment is delayed.

The episode covers capacity versus competency, surrogate and physician consent in emergencies, the emotional weight of amputation decisions, and a four-phase consent model to help patients understand trajectories and make informed choices.

In this episode Dr. G explains how Newton’s laws of motion illuminate why some diabetic foot ulcers heal and others recur. He connects concepts like force, pressure, shear, and ground reaction forces to real-world biomechanics, footwear, and offloading strategies.

The episode focuses on practical takeaways: managing mechanical loading through appropriate offloading devices, understanding patient activity and adherence, and designing prevention plans so healed wounds stay closed.

Your Story Could Save a Limb: Inside the New Diabetic Foot Ulcer Patient Registry

What if the most important piece of diabetic foot ulcer research isn’t another clinical endpoint—but the patient’s story?

In this special episode of LIMBWatch, Dr. G sits down with Dr. Jared Adams, Senior Vice President of Global Medical Affairs, Digital, and Technology at Alira Health, to explore a powerful new approach to diabetic foot ulcer research: building a patient-centered registry that follows the real-world story of people living with DFUs.

A diabetic foot ulcer is never “just a w...

Episode Summary

In this episode of LIMBWatch, we go beyond the wound itself to explore the science, clinical challenges, and innovations shaping the future of limb preservation.

We are joined by the team behind Lavior, including biomedical scientist and Chief Scientific Officer Dr. David Warren, wound care and hyperbaric medicine specialist Dr. Hanley, wound care podiatrist Dr. Sukoff, and National Sales Director Ashlyn Tapley. 

The conversation explores how Lavior was inspired by the healing properties of Inula viscosa, a medicinal plant with centuries of traditional use, and how the company developed a...

In this episode of Diabetic Fit Files Dr. G explores how the trace element copper affects diabetic foot ulcers at the cellular and molecular level.

Topics include copper's roles in angiogenesis, collagen cross-linking via lysyl oxidase, fibroblast signaling, antimicrobial and anti-biofilm effects, and the promise of controlled copper delivery systems like hydrogels and nanoparticles.

The episode stresses that copper is multifunctional but not a standalone cure: clinical healing depends on addressing vascular, mechanical, and infectious factors as part of a comprehensive limb-salvage approach.

This episode breaks down the neurological exam of the diabetic foot, explaining reflexes, vibration testing, monofilament assessment, proprioception, pinprick and temperature testing, and the autonomic changes that lead to dry skin and fissures.

It shows how different nerve fibers produce paradoxical symptoms, why loss of protective sensation causes silent injuries and ulcers, and why podiatry, vascular assessment and offloading are essential for limb preservation.

This episode explains what to do if you have a diabetic foot ulcer and no health insurance, stressing that you should not ignore the wound or try to self-treat. It covers signs of infection, the need for vascular checks and offloading, and when to seek emergency care.

It also outlines practical options for uninsured patients—community health centers, sliding-fee clinics, hospital charity care—and simple home measures to protect the foot while you arrange professional evaluation.

This episode explores SMAPs — synthetic mimics of antimicrobial peptides — and how they use membrane-targeting chemistry to kill bacteria differently from conventional antibiotics.

It covers the science behind facial amphiphilicity, selectivity versus toxicity, challenges like biofilms and stability, and the potential role of SMAPs as future adjunctive topical therapies for diabetic foot ulcers, while emphasizing they remain experimental and not yet clinical standard of care.

🎙️ Diabetic Foot Files: Limb Watch with Dr. Shilpa Rajan Mulki

What if some amputations could be prevented simply by recognizing the warning signs sooner?

In this episode of Diabetic Foot Files: Limb Watch, Dr. Gabrielle sits down with Dr. Shilpa Rajan Mulki, a diabetologist and diabetic foot and wound-care specialist practicing in Nairobi, Kenya, for a powerful conversation about limb preservation, prevention, and the gaps that can stand between a patient and saving their limb.

Dr. Mulki shares her personal journey into diabetic foot care and explains why multidisciplinary treatment changed the way she approaches compl...

A man who built a global whiskey empire may have been felled not by drink or duel but by a small foot injury that turned infected. This episode examines the legend of Jack Daniel’s toe, the historical accounts of gangrene and “blood poisoning,” and what modern medicine would call sepsis.

Beyond the mystery, the episode delivers a clear medical lesson: tiny wounds can become life-threatening without prompt podiatric and vascular care. Learn why early attention to foot injuries matters and how today’s treatments could have changed the outcome.

This episode explains undermining in diabetic foot ulcers—how tissue destruction can extend beneath intact skin, why wounds may appear larger after debridement, and what that means for healing.

We cover the causes (pressure, neuropathy, ischemia, infection), clinical clues, why proper assessment and debridement matter, and practical prevention tips like offloading, vascular care, infection control, and good diabetes management.

In this episode Dr. G recounts a surprising barracuda bite that exposes the challenges of marine injuries, especially for people with diabetes. The episode explains how sharp lacerations, contamination from seawater, retained debris, and organisms like Vibrio can turn a beach wound into a serious infection.

Key takeaways include immediate bleeding control and irrigation, careful wound assessment (tendons, bone, foreign bodies, tetanus status), cautious use of closure and targeted antibiotics, and the importance of early medical attention — particularly for patients with neuropathy or impaired healing.

This episode reviews Madura foot (mycetoma), a chronic implantation infection characterized by long-standing swelling, multiple sinus tracts, and visible ‘‘grains.’p>

There are two main types — eumycetoma (fungal) and actinomycetoma (bacterial) — with different treatments (antifungals ± surgery vs prolonged antibiotics). Diagnosis relies on deep tissue sampling, culture, histology and imaging to define extent. Early recognition, protective footwear, and daily foot checks are key to limb preservation, especially in patients with diabetes and neuropathy.

Welcome to LIMBWatch — the global movement dedicated to protecting limbs, preventing amputations, and transforming the future of diabetic foot care.

In this landmark episode, we welcome one of the world’s most influential leaders in diabetes and diabetic foot disease — Dr. Andrew Boulton, a pioneer whose research, leadership, and advocacy have shaped modern approaches to neuropathy, diabetic foot screening, and limb salvage.

With more than 600 peer-reviewed publications, an H-index exceeding 130, and decades of international leadership including roles with global diabetes organizations, Dr. Boulton shares lessons from a lifetime dedicated to one mission: preventing unnecessary amputations and im...

This episode clarifies the difference between antimicrobials (agents that act against a range of microorganisms) and antibiotics (drugs that specifically target bacteria), and explains related terms like antiseptics, contamination, colonization, and infection in diabetic foot ulcers.

Dr. G reviews when topical antimicrobial dressings are appropriate, why they do not automatically replace systemic antibiotics, and how debridement, source control, and wound biology guide treatment decisions.

Key takeaways focus on evaluating the wound, understanding product mechanisms, avoiding unnecessary antibiotics through stewardship, and choosing interventions that help heal the patient and protect the limb.

This episode explains why healed wounds can feel tight, covering the stages of wound healing, the role of myofibroblasts and alpha-SMA in wound contraction, and how scar tissue differs from normal skin.

It discusses how diabetes alters healing, the long remodeling phase (months to over a year), practical care tips like moisturization and follow-up, and warning signs that require prompt medical attention.

This episode explores Rhodococcus equi — a pink, soil‑associated bacterium historically linked to horses that can survive inside macrophages and mimic tuberculosis in the lungs.

Dr. G discusses its discovery, how humans become exposed, diagnostic clues (culture, MALDI‑TOF, PCR), challenges in treatment (intracellular survival, prolonged combination antibiotics, and need for surgical source control), and its importance in immunocompromised and diabetic foot wound patients.

This episode traces the history and science behind triple antibiotic ointment—its three ingredients (bacitracin, neomycin, polymyxin B), how they attack different bacteria, and why it became a household staple for minor cuts.

It explains why diabetic foot ulcers are fundamentally different from everyday wounds—driven by neuropathy, poor blood flow, chronic inflammation, biofilm, and deeper infection—and why a topical ointment cannot address these underlying problems.

The episode also covers risks of using ointment on diabetic ulcers (maceration, contact dermatitis, altered wound microbiome), the difference between colonization and infection, and the importance of prompt medica...

Episode Title:
The 10-Gram Test That Can Save a Limb: Understanding Monofilament Screening, Neuropathy & Prevention with Dr. Thomas Hardiman

Episode Summary:

What if one of the simplest tools in diabetic foot care could help prevent devastating complications before they happen?

In this powerful episode of LIMBWatch on Diabetic Foot Files, Dr. Gabrielle Donaldson sits down with Dr. Thomas Hardiman, a podiatric surgeon with over 40 years of experience in foot and ankle care and a pioneer in diabetic foot screening through his work with medical monofilament technology.

Together, they take a...

This episode explores why pain evolved as a critical protective alarm and how diabetes—through chronic high glucose, inflammation, and microvascular damage—silences that alarm by injuring peripheral nerves.

It explains the biological pathways behind diabetic neuropathy, why the feet are especially vulnerable, how repetitive pressure and biofilm-forming bacteria turn painless injuries into ulcers, and the stepwise cascade from nerve damage to amputation.

The episode emphasizes prevention and the clinician’s role as an external warning system: early screening, offloading, proper footwear, glucose control, vascular assessment and coordinated limb-salvage care to protect patients’ feet.

This episode explains gossypiboma (retained surgical sponge), how the body mounts a foreign‑body granuloma response, and why these sponges can mimic infection or tumors and lead to chronic inflammation.

It highlights the added danger for people with diabetes (impaired immunity, poor circulation, neuropathy), shares a real diagnostic case, and reviews prevention steps like sponge counts, radiopaque markers, barcode systems, and surgical timeouts. The key message: persistent non‑healing wounds often need a detective approach to look beneath the surface.

Melioidosis is an infection caused by the soil and water bacterium Burkholderia pseudomallei that can enter through cuts, wounds, or inhalation. It often mimics common conditions—pneumonia, tuberculosis, routine wound infections, or chronic diabetic foot infections—making diagnosis challenging.

People with diabetes are at higher risk, and proper diagnosis requires culture and targeted therapy (IV intensive antibiotics such as ceftazidime or meropenem followed by prolonged oral eradication therapy). Prevention focuses on reducing soil and water exposure, protective footwear, wound care, and detailed environmental history for at-risk patients.

The below-the-knee amputation (BKA) is a common major limb loss in people with diabetes, resulting from a long pathway of neuropathy, vascular disease, biomechanical breakdown, ulcers, and infection. Modern amputation philosophy focuses on preserving the knee to maximize function, but BKA remains a marker of advanced systemic disease with significant morbidity and mortality.

Preserving the knee improves mobility, energy efficiency, and prosthetic outcomes; yet prevention is crucial. Early screening, offloading, wound care, vascular assessment, and multidisciplinary limb-salvage teams—especially podiatrists working with vascular and infectious disease specialists—are key to stopping the progression that leads to amputation.

LIMBWatch Series | Dr. Paula DeJesus DPM, FACFAS, : The Future of Limb Salvage Through Minimally Invasive Surgery
In this episode of the LIMBWatch Series on Diabetic Foot Files  sits with Dr. Lady Paula DeJesus DPM, FACFAS, DABPM, CWSP— a triple board‑certified podiatric surgeon and Section Chief at Yale New Haven Health Greenwich Hospital
Dr. Dejesus shares her remarkable journey into podiatric medicine and discusses the clinical decision-making behind complex diabetic foot infections, osteomyelitis, peripheral arterial disease, and limb preservation. She explains how minimally invasive surgical techniques are transforming diabetic limb salvage, including innovative approaches to treating calcaneal osteo...

LIMBWatch Series | Dr. Paula DeJesus DPM, FACFAS, : The Future of Limb Salvage Through Minimally Invasive Surgery

In this episode of the LIMBWatch Series on Diabetic Foot Files  sits with Dr. Lady Paula DeJesus DPM, FACFAS, DABPM, CWSP— a triple board‑certified podiatric surgeon and Section Chief at Yale New Haven Health Greenwich Hospital

Dr. Dejesus shares her remarkable journey into podiatric medicine and discusses the clinical decision-making behind complex diabetic foot infections, osteomyelitis, peripheral arterial disease, and limb preservation. She explains how minimally invasive surgical techniques are transforming diabetic limb salvage, including innovative approaches to treat...

Dr. G examines how diabetic toes and ulcers are rarely just wounds but visible warnings of neuropathy, poor circulation, infection, and gaps in care. She asks who is responsible for protecting the foot — the patient, primary care, podiatry, vascular, infectious disease, surgery, or nursing — and how fragmented referrals and delayed access can lead to a cascade ending in amputation.

The episode also explains hospital handling of amputated tissue, patients’ rights to their removed parts, and the future of limb preservation through surveillance technologies and coordinated responsibility to prevent avoidable loss.

This episode introduces edge trenching, a novel debridement technique developed by Dr. Igor Melnichuk that targets dysfunctional wound edges (epibolies, hyperkeratosis, rolled or fibrotic margins) to create a biologically active transition zone and promote epithelial migration.

It explains the procedure, proposed mechanisms, clinical use—especially in diabetic plantar ulcers—how trenches are created and repeated, and emphasizes that edge trenching must be part of comprehensive care addressing perfusion, infection control, offloading, and underlying causes.

Dr. Giulia Baldazzi, a vascular surgeon, fellow and phd candidate researcher, shares her journey from UCSF to Italy and explores advances in perfusion assessment, revascularization, and limb preservation for diabetic foot care.

She discusses diagnostic innovations (PAT, MaxCORE, NIRS), the importance of early vascular referral and multidisciplinary teams, and practical strategies to prevent amputations and improve healing.

Actinomycosis is a rare, slow-growing filamentous gram-positive bacterial infection that can mimic cancer, tuberculosis, or chronic diabetic foot infections by producing woody fibrosis, interconnected sinus tracts, and characteristic yellow "sulfur" granules.

Diagnosis requires deep tissue biopsy and careful anaerobic culture or histology; treatment is prolonged high‑dose penicillin (or alternatives if allergic) often combined with surgical drainage and debridement.

In this episode of Diabetics with Files, Dr. G explains liquid biopsies — blood tests that detect cell-free DNA and other molecular signals — and how they work.

We explore how this technology could help detect infection early, identify harmful inflammation, predict a wound’s healing potential, and personalize treatment for diabetic foot ulcers.

The episode also covers current limitations — cost, access, standardization, and need for clinical validation — and explains that liquid biopsies would complement, not replace, clinical exams and imaging.

Ultimately, liquid biopsies could shift wound care from reactive to predictive and improve limb salvage in...

This episode explains how chronic wounds—especially heavily exudative and diabetic ulcers—act like metabolic drains, leaking proteins, growth factors, immune cells, electrolytes, and calories and impairing the body’ s ability to heal.

Listen for signs of protein loss (low albumin, persistent drainage, weight/muscle loss, delayed healing) and practical strategies to fight back: infection control, offloading, appropriate compression, nutrition optimization, and closing the wound to stop the ongoing resource loss.

LIMBWatch | Dr. David B. Alper – The Policy Behind Preventing Amputations

Why are so many lower extremity amputations still happening when the majority could be prevented?

In this powerful episode of LIMBWatch, Dr. Gabrielle Hutcheson sits down with nationally recognized limb preservation advocate Dr. David B. Alper, DPM, to explore the critical intersection of healthcare policy, reimbursement, advocacy, and limb salvage. Drawing on decades of clinical experience and legislative leadership, Dr. Alper explains why preventing amputations requires more than excellent medicine—it requires changing the healthcare system itself.

Together, they discuss the barriers clinicians face...

In this episode , one of the world’s most influential pioneers in limb preservation, Dr.David Armstrong DPM, MD, PhD Distinguished Professor of Surgery and Neurological Surgery and a Global Leader in limb preservation whose research has fundamentally changed how clinicians approach diabetic foot disease.

Dr. Armstrong shares the personal story that inspired his lifelong mission to prevent amputations, describing two unforgettable patients whose experiences taught him one of medicine’s greatest lessons—that the absence of pain can be more dangerous than pain itself.

Throughout the conversation, he explains why diabetic foot ulcers remain one of...

This episode explains the crucial difference between hypoxia (low oxygen that can trigger repair) and ischemia (lack of blood flow that deprives tissue of oxygen, nutrients, and immune cells), and how diabetes worsens both.

Clinical takeaways: check vascular status with toe pressures and TcPO2 before escalating to advanced wound therapies, and prioritize revascularization when needed to give wounds a real chance to heal.

Dr. G explains how hypoxia‑inducible factor 1 alpha (HIF‑1α) acts as the cell's oxygen sensor and coordinator of wound repair, why diabetes disrupts its signaling, and how that impairment stalls healing in diabetic foot ulcers.

The episode summarizes how researchers measure HIF‑1α, and reviews emerging treatments—HIF stabilizers, gene/RNA therapies, stem cells, engineered scaffolds, and oxygen‑releasing biomaterials—that aim to restore molecular healing pathways and improve limb salvage.

This episode explains how xylazine ("tranq"), a veterinary sedative now found in the illicit drug supply, is causing severe, fast-progressing wounds and infections when mixed with fentanyl.

It reviews the drug's vasoconstrictive effects, wound features (necrosis, deep infection, slow healing), key differences from diabetic foot ulcers, treatment priorities (debridement, antibiotics, advanced wound care), and the need for compassionate, comprehensive care and referral for substance use disorders.

In this episode of Limb Watch Series with Diabetic Foot Files, host interviews Jason Ayers, a wound care RN and inventor of a topical oxygen hydrotherapy kit that combines warmed antimicrobial cleansing solution with localized oxygen bubbles to cleanse and promote healing in chronic wounds, especially diabetic foot ulcers.

Jason explains the origin and prototype development, demonstrates a typical 10–15 minute treatment session, and shares case-study results showing faster cleansing, improved tissue color, reduced drainage and odor, and positive patient feedback.

The discussion covers how the device fits into current debridement tools, safety and infection-control design ch...

In this episode of Diabetic Foot Files Dr. G explores the overlooked foot–liver connection: how liver metabolism, protein synthesis, clotting, and inflammation influence wound healing, infection risk, and limb salvage in people with diabetes.

Topics include metabolic dysfunction-associated steatotic liver disease (MASLD), low albumin, sarcopenia, key labs and imaging to consider, and practical steps clinicians can take to address systemic contributors to delayed healing.

Takeaway: diabetic foot ulcers are rarely just a local problem—optimizing liver health, nutrition, glycemic control, and systemic care improves healing and reduces amputation risk.

This episode traces coffee’s journey and asks whether daily caffeine affects diabetic foot ulcer healing.

It summarizes the science on how caffeine influences blood vessels, sleep, blood sugar, inflammation, fibroblasts, and hydration, and explains that moderate, unsweetened coffee is unlikely to severely impair healing while excessive intake, sugary drinks, poor sleep, or circulation issues can hinder recovery.

Practical advice is given: consult your doctor or nutritionist, prioritize overall wound care (circulation, glycemic control, nutrition, sleep, hydration), and consider alternatives like green or herbal teas when appropriate.